{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:18:57Z","timestamp":1778887137261,"version":"3.51.4"},"reference-count":65,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Science and Technological Development, Republic of Serbia","award":["451-03-47\/2023-01\/200042"],"award-info":[{"award-number":["451-03-47\/2023-01\/200042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dysregulated expression of the long non-coding RNA MALAT1 has been implicated in the pathogenesis and progression of a variety of cancers, including hematological malignancies, but it has been poorly investigated in chronic lymphocytic leukemia (CLL). In this study, the expression of MALAT1 was measured using a quantitative reverse-transcriptase polymerase chain reaction in the peripheral blood mononuclear cells of 114 unselected, newly diagnosed CLL patients in order to analyze its association with clinical, laboratory, and molecular patients\u2019 characteristics at diagnosis, as well as its prognostic relevance. MALAT1 was found to be upregulated in CLL patients in comparison to healthy controls, and expression levels were not related to age, leukocyte, lymphocyte and platelet count, serum \u03b22-microglobulin, and IGHV somatic hypermutational status. On the other hand, high MALAT1 expression was associated with several favorable prognostic markers (high hemoglobin, low serum lactate dehydrogenase, earlier clinical stages, CD38-negative status), but also with unfavorable cytogenetics. Furthermore, an association between high MALAT1 levels and longer time to first treatment and overall survival in IGHV-unmutated CLL subtype was observed. In summary, our results imply that high MALAT1 expression at diagnosis may be a predictor of better prognosis and point to MALAT1 expression profiling as a candidate biomarker potentially useful in clinical practice.<\/jats:p>","DOI":"10.3390\/ijms25020922","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T06:52:14Z","timestamp":1704955934000},"page":"922","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic Leukemia"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1573-570X","authenticated-orcid":false,"given":"Kristina","family":"Tomic Vujovic","sequence":"first","affiliation":[{"name":"Clinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Ugrin","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-6215","authenticated-orcid":false,"given":"Natasa","family":"Tosic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vojin","family":"Vukovic","sequence":"additional","affiliation":[{"name":"Clinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Marjanovic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Kostic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-535X","authenticated-orcid":false,"given":"Sanja","family":"Stankovic","sequence":"additional","affiliation":[{"name":"Center for Medical Biochemistry, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Department of Biochemistry, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8690-1357","authenticated-orcid":false,"given":"Vladimir","family":"Otasevic","sequence":"additional","affiliation":[{"name":"Clinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofija","family":"Sarac","sequence":"additional","affiliation":[{"name":"Clinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-1342","authenticated-orcid":false,"given":"Darko","family":"Antic","sequence":"additional","affiliation":[{"name":"Clinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"School of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Pavlovic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6156-0584","authenticated-orcid":false,"given":"Teodora","family":"Karan-Djurasevic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhang, X., Wang, W., Zhu, W., Dong, J., Cheng, Y., Yin, Z., and Shen, F. (2019). Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225573"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Arun, G., Aggarwal, D., and Spector, D.L. (2020). MALAT1 Long Non-Coding RNA: Functional Implications. Noncoding RNA, 6.","DOI":"10.3390\/ncrna6020022"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bbagen.2013.10.035","article-title":"Evolutionary conservation of long non-coding RNAs; sequence, structure, function","volume":"1840","author":"Johnsson","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"GTEx Consortium (2017). Genetic effects on gene expression across human tissues. Nature, 550, 204\u2013213.","DOI":"10.1038\/nature24277"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nsmb.2844","article-title":"Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix","volume":"21","author":"Brown","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hutchinson, J.N., Ensminger, A.W., Clemson, C.M., Lynch, C.R., Lawrence, J.B., and Chess, A. (2007). A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genom., 8.","DOI":"10.1186\/1471-2164-8-39"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1261\/rna.028639.111","article-title":"Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles","volume":"18","author":"Miyagawa","year":"2012","journal-title":"RNA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/nar\/gky1171","article-title":"Finely tuned conformational dynamics regulate the protective function of the lncRNA MALAT1 triple helix","volume":"47","author":"Ageeli","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1093\/nar\/gkz1176","article-title":"The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis","volume":"48","author":"Nguyen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molcel.2010.08.011","article-title":"The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation","volume":"39","author":"Tripathi","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molcel.2014.07.012","article-title":"The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites","volume":"55","author":"West","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2014.08.018","article-title":"RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites","volume":"159","author":"Engreitz","year":"2014","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"29365","DOI":"10.1074\/jbc.M114.572693","article-title":"Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma","volume":"289","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bbrc.2018.06.086","article-title":"Long non-coding RNA MALAT1 interacts with transcription factor Foxo1 to regulate SIRT1 transcription in high glucose-induced HK-2 cells injury","volume":"503","author":"Zhou","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.omtn.2019.05.009","article-title":"Silencing of lncRNA MALAT1 Prevents Inflammatory Injury after Lung Transplant Ischemia-Reperfusion by Downregulation of IL-8 via p300","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2011.08.054","article-title":"ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs","volume":"147","author":"Yang","year":"2011","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"106527","DOI":"10.18632\/oncotarget.22507","article-title":"Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma","volume":"8","author":"Stamato","year":"2017","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41045","DOI":"10.18632\/oncotarget.5728","article-title":"LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"31305","DOI":"10.18632\/oncotarget.15453","article-title":"Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"116335","DOI":"10.1016\/j.lfs.2019.03.040","article-title":"LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195","volume":"231","author":"Wang","year":"2019","journal-title":"Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1002\/jcp.26185","article-title":"Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b\/STAT3 axis","volume":"233","author":"Chang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"54733","DOI":"10.18632\/oncotarget.10752","article-title":"MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63901","DOI":"10.18632\/oncotarget.11564","article-title":"Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22","volume":"7","author":"Luan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jcp.26759","article-title":"Functions and regulatory mechanisms of metastasis-associated lung adenocarcinoma transcript 1","volume":"234","author":"Lei","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-018-0606-4","article-title":"MALAT1: A druggable long non-coding RNA for targeted anti-cancer approaches","volume":"11","author":"Amodio","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10181","DOI":"10.2147\/CMAR.S276022","article-title":"Regulatory Networks of LncRNA MALAT-1 in Cancer","volume":"12","author":"Fu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fgene.2020.00093","article-title":"The Oncogenic and Tumor Suppressive Functions of the Long Noncoding RNA MALAT1: An Emerging Controversy","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.7150\/jca.14663","article-title":"The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature","volume":"7","author":"Wang","year":"2016","journal-title":"J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.seminhematol.2014.05.003","article-title":"The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia","volume":"51","author":"Stevenson","year":"2014","journal-title":"Semin. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41375-022-01604-2","article-title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: The 2022 update of the recommendations by ERIC, the European Research Initiative on CLL","volume":"36","author":"Agathangelidis","year":"2022","journal-title":"Leukemia"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fabris, L., Juracek, J., and Calin, G. (2020). Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186720"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lingua, M.F., Carra, G., Maffeo, B., and Morotti, A. (2021). Non-Coding RNAs: The \u201cDark Side Matter\u201d of the CLL Universe. Pharmaceuticals, 14.","DOI":"10.3390\/ph14020168"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gasic, V., Karan-Djurasevic, T., Pavlovic, D., Zukic, B., Pavlovic, S., and Tosic, N. (2022). Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. Life, 12.","DOI":"10.3390\/life12111770"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13148-016-0274-6","article-title":"Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL","volume":"8","author":"Subhash","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1038\/bcj.2016.77","article-title":"lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome","volume":"6","author":"Ronchetti","year":"2016","journal-title":"Blood Cancer J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5045\/br.2018.53.4.320","article-title":"Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings","volume":"53","author":"Ahmadi","year":"2018","journal-title":"Blood Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16839","DOI":"10.1038\/s41598-023-44174-8","article-title":"MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms","volume":"13","author":"Nadeu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.critrevonc.2017.08.011","article-title":"Emerging roles for long noncoding RNAs in B-cell development and malignancy","volume":"120","author":"Winkle","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dahl, M., Kristensen, L.S., and Gronbaek, K. (2018). Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092475"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"577890","DOI":"10.3389\/fonc.2020.577890","article-title":"The Role of Noncoding RNAs in B-Cell Lymphoma","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopha.2017.02.011","article-title":"The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma","volume":"89","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-016-1100-9","article-title":"LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2","volume":"14","author":"Wang","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Cho, S.F., Chang, Y.C., Chang, C.S., Lin, S.F., Liu, Y.C., Hsiao, H.H., Chang, J.G., and Liu, T.C. (2014). MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-809"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjh.14882","article-title":"Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma","volume":"179","author":"Handa","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cca.2014.02.010","article-title":"Investigation of circulating lncRNAs in B-cell neoplasms","volume":"431","author":"Isin","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.18632\/oncotarget.7442","article-title":"Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma","volume":"7","author":"Ronchetti","year":"2016","journal-title":"Oncotarget"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","article-title":"Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1080\/15384101.2019.1652034","article-title":"LncRNA MALAT1\/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway","volume":"18","author":"Sun","year":"2019","journal-title":"Cell Cycle"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00432-020-03127-8","article-title":"Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis","volume":"146","author":"Liu","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4236\/jct.2013.43094","article-title":"Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus models","volume":"4","author":"Jeffers","year":"2013","journal-title":"J. Cancer Ther."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ma, X.Y., Wang, J.H., Wang, J.L., Ma, C.X., Wang, X.C., and Liu, F.S. (2015). Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells. BMC Genom., 16.","DOI":"10.1186\/s12864-015-1881-x"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Tripathi, V., Shen, Z., Chakraborty, A., Giri, S., Freier, S.M., Wu, X., Zhang, Y., Gorospe, M., Prasanth, S.G., and Lal, A. (2013). Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003368"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9947","DOI":"10.1093\/nar\/gkx600","article-title":"Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation","volume":"45","author":"Chen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fgene.2017.00208","article-title":"Identification of Minimal p53 Promoter Region Regulated by MALAT1 in Human Lung Adenocarcinoma Cells","volume":"8","author":"Tano","year":"2017","journal-title":"Front. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ajh.24493","article-title":"The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients","volume":"91","author":"Molica","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/cyto.b.20363","article-title":"2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia","volume":"72","author":"Wood","year":"2007","journal-title":"Cytometry B Clin. Cytom."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/cyto.b.20365","article-title":"2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications","volume":"72","author":"Davis","year":"2007","journal-title":"Cytometry B Clin. Cytom."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/leu.2017.125","article-title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: Updated ERIC recommendations","volume":"31","author":"Rosenquist","year":"2017","journal-title":"Leukemia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41375-017-0007-7","article-title":"ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation","volume":"32","author":"Malcikova","year":"2018","journal-title":"Leukemia"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"International CLL-IPI working group (2016). An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): A meta-analysis of individual patient data. Lancet Oncol., 17, 779\u2013790.","DOI":"10.1016\/S1470-2045(16)30029-8"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/922\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:44:36Z","timestamp":1760103876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25020922"],"URL":"https:\/\/doi.org\/10.3390\/ijms25020922","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}